Literature DB >> 21363924

The DeltaNp63 proteins are key allies of BRCA1 in the prevention of basal-like breast cancer.

Niamh E Buckley1, Susan J Conlon, Karin Jirstrom, Elaine W Kay, Nyree T Crawford, Anthony O'Grady, Katherine Sheehan, Simon S Mc Dade, Ching-Wei Wang, Dennis J McCance, Patrick G Johnston, Richard D Kennedy, D Paul Harkin, Paul B Mullan.   

Abstract

Little is known about the origin of basal-like breast cancers, an aggressive disease that is highly similar to BRCA1-mutant breast cancers. p63 family proteins that are structurally related to the p53 suppressor protein are known to function in stem cell regulation and stratified epithelia development in multiple tissues, and p63 expression may be a marker of basal-like breast cancers. Here we report that ΔNp63 isoforms of p63 are transcriptional targets for positive regulation by BRCA1. Our analyses of breast cancer tissue microarrays and BRCA1-modulated breast cancer cell lines do not support earlier reports that p63 is a marker of basal-like or BRCA1 mutant cancers. Nevertheless, we found that BRCA1 interacts with the specific p63 isoform ΔNp63γ along with transcription factor isoforms AP-2α and AP-2γ. BRCA1 required ΔNp63γ and AP-2γ to localize to an intronic enhancer region within the p63 gene to upregulate transcription of the ΔNp63 isoforms. In mammary stem/progenitor cells, siRNA-mediated knockdown of ΔNp63 expression resulted in genomic instability, increased cell proliferation, loss of DNA damage checkpoint control, and impaired growth control. Together, our findings establish that transcriptional upregulation of ΔNp63 proteins is critical for BRCA1 suppressor function and that defects in BRCA1-ΔNp63 signaling are key events in the pathogenesis of basal-like breast cancer. ©2011 AACR.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21363924     DOI: 10.1158/0008-5472.CAN-10-2717

Source DB:  PubMed          Journal:  Cancer Res        ISSN: 0008-5472            Impact factor:   12.701


  24 in total

Review 1.  BRCA1--conductor of the breast stem cell orchestra: the role of BRCA1 in mammary gland development and identification of cell of origin of BRCA1 mutant breast cancer.

Authors:  Niamh E Buckley; Paul B Mullan
Journal:  Stem Cell Rev Rep       Date:  2012-09       Impact factor: 5.739

2.  FANCD2 activates transcription of TAp63 and suppresses tumorigenesis.

Authors:  Eunmi Park; Hyungjin Kim; Jung Min Kim; Benjamin Primack; Sofia Vidal-Cardenas; Ye Xu; Brendan D Price; Alea A Mills; Alan D D'Andrea
Journal:  Mol Cell       Date:  2013-06-27       Impact factor: 17.970

3.  p63/MT1-MMP axis is required for in situ to invasive transition in basal-like breast cancer.

Authors:  C Lodillinsky; E Infante; A Guichard; R Chaligné; L Fuhrmann; J Cyrta; M Irondelle; E Lagoutte; S Vacher; H Bonsang-Kitzis; M Glukhova; F Reyal; I Bièche; A Vincent-Salomon; P Chavrier
Journal:  Oncogene       Date:  2015-04-20       Impact factor: 9.867

4.  p63 isoforms in triple-negative breast cancer: ΔNp63 associates with the basal phenotype whereas TAp63 associates with androgen receptor, lack of BRCA mutation, PTEN and improved survival.

Authors:  Philip J Coates; Rudolf Nenutil; Jitka Holcakova; Marta Nekulova; Jan Podhorec; Marek Svoboda; Borivoj Vojtesek
Journal:  Virchows Arch       Date:  2018-02-27       Impact factor: 4.064

5.  ΔNp63α induces quiescence and downregulates the BRCA1 pathway in estrogen receptor-positive luminal breast cancer cell line MCF7 but not in other breast cancer cell lines.

Authors:  Ruhul Amin; Yuiko Morita-Fujimura; Hiroshi Tawarayama; Kentaro Semba; Natsuko Chiba; Manabu Fukumoto; Shuntaro Ikawa
Journal:  Mol Oncol       Date:  2015-11-24       Impact factor: 6.603

6.  BRCA1/FANCD2/BRG1-Driven DNA Repair Stabilizes the Differentiation State of Human Mammary Epithelial Cells.

Authors:  Hua Wang; Brian Bierie; Andrew G Li; Shailja Pathania; Kimberly Toomire; Stoil D Dimitrov; Ben Liu; Rebecca Gelman; Anita Giobbie-Hurder; Jean Feunteun; Kornelia Polyak; David M Livingston
Journal:  Mol Cell       Date:  2016-06-30       Impact factor: 17.970

7.  Trp63 is regulated by STAT5 in mammary tissue and subject to differentiation in cancer.

Authors:  Shahin Assefnia; Keunsoo Kang; Svenja Groeneveld; Daisuke Yamaji; Sarah Dabydeen; Ahmad Alamri; Xuefeng Liu; Lothar Hennighausen; Priscilla A Furth
Journal:  Endocr Relat Cancer       Date:  2014-05-06       Impact factor: 5.678

8.  ΔNp63 regulates cell proliferation, differentiation, adhesion, and migration in the BL2 subtype of basal-like breast cancer.

Authors:  Paulina Orzol; Marta Nekulova; Jitka Holcakova; Petr Muller; Borivoj Votesek; Philip J Coates
Journal:  Tumour Biol       Date:  2016-01-29

9.  Expression and Clinical Significance of Claudin-7, PDL-1, PTEN, c-Kit, c-Met, c-Myc, ALK, CK5/6, CK17, p53, EGFR, Ki67, p63 in Triple-negative Breast Cancer-A Single Centre Prospective Observational Study.

Authors:  Chloe Constantinou; Savvas Papadopoulos; Eirini Karyda; Athanasios Alexopoulos; Niki Agnanti; Anna Batistatou; Haris Harisis
Journal:  In Vivo       Date:  2018 Mar-Apr       Impact factor: 2.155

10.  HuR is necessary for mammary epithelial cell proliferation and polarity at least in part via ΔNp63.

Authors:  Wensheng Yan; Yanhong Zhang; Jin Zhang; Seong-Jun Cho; Xinbin Chen
Journal:  PLoS One       Date:  2012-09-18       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.